PARP Inhibition, a New Therapeutic Avenue in Patients with Prostate Cancer Ronan FlippotAnna PatrikidouKarim Fizazi Review Article 05 May 2022 Pages: 719 - 733
Lupus Nephritis: Improving Treatment Options Myrto KostopoulouSofia PitsigavdakiGeorge Bertsias Review Article 29 April 2022 Pages: 735 - 748
New Drug Delivery Systems Developed for Brain Targeting Shruti U. RawalBhoomika M. PatelMayur M. Patel Review Article 21 May 2022 Pages: 749 - 792
Adverse Events Associated with Immune Checkpoint Inhibitors: Overview of Systematic Reviews Salmaan KanjiSydney MorinBrian Hutton Systematic Review 13 April 2022 Pages: 793 - 809
Pralsetinib: A Review in Advanced RET Fusion-Positive NSCLC Yahiya Y. Syed Adis Drug Evaluation 19 May 2022 Pages: 811 - 816
Correction to: Benefits and Harms of ‘Smart Drugs’ (Nootropics) in Healthy Individuals Fabrizio SchifanoValeria CatalaniAmira Guirguis Correction 27 April 2022 Pages: 839 - 839
Correction to: Daridorexant: First Approval Anthony Markham Correction Open access 27 April 2022 Pages: 841 - 841